# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001728117-25-000021
Filing Date
2025-03-13
Accepted
2025-03-13 16:01:37
Documents
96
Period of Report
2024-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | goss-20241231.htm iXBRL | 10-K | 1964316
2 | EX-10.7 | goss-20241231xexx107xdirec.htm | EX-10.7 | 141601
3 | EX-19.1 | goss-20241231xexx191xinsid.htm | EX-19.1 | 52182
4 | EX-21.1 | goss-20241231xexx211xlisto.htm | EX-21.1 | 3287
5 | EX-23.1 | goss-20241231xexx231xeycon.htm | EX-23.1 | 3362
6 | EX-31.1 | goss-20241231x10kexx311.htm | EX-31.1 | 8312
7 | EX-31.2 | goss-20241231x10kexx312.htm | EX-31.2 | 8323
8 | EX-32.1 | goss-20241231x10kexx321.htm | EX-32.1 | 3640
9 | EX-32.2 | goss-20241231x10kexx322.htm | EX-32.2 | 3652
15 | GRAPHIC | goss-20241231_g1.jpg | GRAPHIC | 31835
16 | GRAPHIC | goss-20241231_g2.jpg | GRAPHIC | 333975
| Complete submission text file | 0001728117-25-000021.txt |  | 10678447

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
10 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | goss-20241231.xsd | EX-101.SCH | 67391
11 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | goss-20241231_cal.xml | EX-101.CAL | 93298
12 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | goss-20241231_def.xml | EX-101.DEF | 315034
13 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | goss-20241231_lab.xml | EX-101.LAB | 848455
14 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | goss-20241231_pre.xml | EX-101.PRE | 579092
99 | EXTRACTED XBRL INSTANCE DOCUMENT | goss-20241231_htm.xml | XML | 1222761

Mailing Address 3115 MERRYFIELD ROW SUITE 120 SAN DIEGO CA 92121
Business Address 3115 MERRYFIELD ROW SUITE 120 SAN DIEGO CA 92121 (858) 684-1300
Gossamer Bio, Inc. (Filer) CIK: 0001728117 (see all company filings)

EIN.: 475461709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38796 | Film No.: 25735631
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)